Heze Development Zone chuangli Chemical Co., Ltd.

Firmenname:Heze Development Zone chuangli Chemical Co., Ltd.
Telefon:0530-+86-530-529 6766,+86-15666160102
E-Mail:info@chuangli-chem.com
Nationalität:China
URL: https://www.chemicalbook.com/supplier/10660012/
Produkte insgesamt:869
1 2 3 4 5 6 7 8 9

Produktkatalog

2-(4-((9S,13S)-9,13-Bis(Tert-Butoxycarbonyl)-18,18-Dimethyl-3,11,16-Trioxo-17-Oxa-2,4,10,12-Tetraazanonadecyl)Phenyl)Acetic Acid1610413-97-2C34H54N4O10
3-Nitrodibenzofuran5410-97-9C12H7NO3
2-azido-2-deoxy-D-mannose97604-58-5C6H11N3O5
Fmoc-Phe-Lys(Boc)-PAB-PNP1646299-50-4C49H51N5O11
RGD(DY)K, RGD cyclic peptide
MAC-545496838810-96-1C18H18ClN5O3S
Tubulin inhibitor 6105925-39-1C20H14ClNO2S
2-BROMO-5-METHOXYBENZONITRILE138642-47-4C8H6BrNO
1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE)1193389-40-0C10H13BrClN
Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate1032350-06-3C15H20BrNO2
PF 02341066 hydrochloride1415560-69-8C21H23Cl3FN5O
VLX6001622945-04-3C17H17N7
Inarigivir (ORI-9020, SB-9000)475650-36-3C20H26N7O10PS
PTCDI-C476372-76-4C40H26N2O4
NS-398123653-11-2C13H18N2O5S
(3-BROMOPHENYL)-(6-NITROQUINAZOLIN-4-YL)AMINE169205-77-0C14H9BrN4O2
5-Chloropyrimidine-2-Carboxylic Acid Methyl Ester894797-00-3C6H5ClN2O2
1-(4-nitrophenyl)cyclobutan-1-amine1260672-25-0C10H12N2O2
1G244847928-32-9C29H30F2N4O2
2-Amino-4-methoxypyridine10201-73-7C6H8N2O
TH54872304947-71-3C19H18BrIN4O2
5-(1H-Indol-3-ylmethyl)imidazolidine-2,4-dione21753-16-2C12H11N3O2
4,7,10,13-Tetraoxapentadecanoic acid, 15-amino-, methyl ester1263044-69-4C12H25NO6
DGY-06-1162556836-50-9C32H33ClN8O2
Fmoc-Val-MC-Phe-PAB-Lys(Trt)-ONAla-PAB-OH
3-(4-CHLOROPHENYL)PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER886767-49-3C15H21ClN2O2
3-AMINODIBENZOFURAN4106-66-5C12H9NO
1,4-Bis(chloromethyl)-2,5-dimethoxybenzene3752-97-4C10H12Cl2O2
Emapunil226954-04-7C23H23N5O2
ADU-S100 ammonium salt1638750-96-5C20H27N11O10P2S2
Valnivudine956483-03-7C27H35N3O6*ClH
18-(4-(5,5-difluoro-5H-4l4,5l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-10-yl)phenyl)octadecyl (2-(trimethylammonio)ethyl) phosphat1250963-36-0C38H59BF2N3O3P
N-[3-[[5-Fluoro-2-[[4-[(2-methoxyethoxy)methoxy]phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide1616380-54-1C23H24FN5O4
6-Chloropyridazine-3-carboxylic acid5096-73-1C5H3ClN2O2
Pifithrin-μ64984-31-2C8H7NO2S
RGD(DF)C, RGD cyclic peptide
IM1561422365-93-2C13H16F3N5O
METHYL 6-CHLOROPYRIDAZINE-3-CARBOXYLATE65202-50-8C6H5ClN2O2
Aurora kinase inhibitor III879127-16-9C21H18F3N5O
G-KG1460-59-9C16H16
BD1063 HCl206996-13-6C13H19Cl3N2
HM30181 (Mesylate)849675-87-2C39H40N6O10S
ODM-2011297538-32-9C19H19ClN6O2
SCH 51344171927-40-5C16H20N4O3
RH01687302901-13-9C12 H9 Cl N6 O2 S
STING agonist-42138300-40-8C34H38N12O4
R configuration CPI169
BO-2642408648-20-2C18H19N5O3
GSK6202088410-46-0C18H19N3O3
Fmoc-Phe-Lys(Trt)-PAB1116085-98-3C56H54N4O5
3-Pyridinecarboxylic acid, 5-chloro-2-methyl-1092286-30-0C7H6ClNO2
TAK 6321228591-30-7C27H18F4N4O3S
CDKI-731421693-22-2C15H15FN6O2S2
AZD37591626387-80-1C22H23ClFN5O3
TA 011784751-18-3C20H12F3N3
1,1'-Biphenyl, 2-iodo-6-methoxy-84253-78-1C13H11IO
MSAB173436-66-3C15H15NO4S
2-CHLORO-5-NITROPYRIMIDIN-4-AMINE2-Chlor-5-nitropyrimidin-4-amin1920-66-7C4H3ClN4O2
ZT-12-037-012328073-61-4C21H31N5O2
MC-Gly-Gly-Phe1599440-15-9C23H28N4O7
2-(2-methoxyphenyl)-4H-isoquinoline-1,3-dione106128-44-3C16H13NO3
NS-3-008(HCl)1172854-54-4C14H24ClN3
Guanosine, N-(2-methyl-1-oxopropyl)-, 2',3'-bis(2-methylpropanoate)56489-75-9C22H31N5O8
Entacapone130929-57-6C14H15N3O5
8-methoxy-2-(di-n-propylamino)tetralin3897-94-7C17H27NO
Rigosertib sodium592542-60-4C21H24NNaO8S
Phe-Lys(Trt)-PAB1116085-99-4C41H44N4O3
BRD75521137359-47-7C33H33N3O15
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1)1369427-40-6C26H48N2O5
RARECHEM AL BF 018421233-61-4C11H9NO2
NDI-0911432375840-87-0C20H14ClF2NO5S
INCB0865502378608-10-5
5-nitro-2-methylbenzo[d][1,3]oxazin-4-one412341-84-5C9H6N2O4
tert-Butyl 1-(4-aMinophenyl)cyclobutylcarbaMate1259224-00-4C15H22N2O2
N,N-dimethyl-2-oxo-1,3-dihydroindole-5-sulfonamide170565-89-6C10H12N2O3S
P-NITROPHENYL PROPIONATE4-Nitrophenylpropionat1956-06-5C9H9NO4
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide182182-31-6C13H15FN2O2
BAY-8002724440-27-1C20H14ClNO5S
ML-1091186649-91-1C31H29N3O5
Hydrazinium hydroxide1805818-57-8C15H19ClFNO4
RGD(DF)K, RGD cyclic peptide
NV-51382095886-80-7C7H13F2NO2
4-Chloropyridine-2-carboxamide99586-65-9C6H5ClN2O
1-(4-BROMOPHENYL)CYCLOBUTANECARBOXYLIC ACID151157-49-2C11H11BrO2
LY 26063681234015-52-1C18H19N7O2
TA 021784751-19-4C20H13F2N3
Emixustat Hydrochloride942195-55-3C20H19F2N3O3
V-93021855871-76-9C34H38N2O4
2,3-Dihydro-Phenazine19220-18-9C12H8N2O2
CYCLO(-PHE-PRO)(3S-trans)-3-Benzylhexahydropyrrolo[1,2-a]pyrazin-1,4-dion3705-26-8C14H16N2O2
MC-GGFG1599490-25-1
5-Pyrimidinecarboxylic acid, 1,4-dihydro-4-oxo- (9CI)65754-04-3C5H4N2O3
C75191282-48-1C14H22O4
3-Iodo-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine862730-04-9C8H10IN5
SAR 1316751433953-83-3C18H22N4O4
acetone-[bis-(2-amino-ethyl)-dithioacetal]22907-30-8C7H18N2S2
POL1 inhibitor1822358-25-7C21H20N6
BAY K 864471145-03-4C16H15F3N2O4
CH69537552055918-71-1C26H22F2N6O4S
1 2 3 4 5 6 7 8 9
Copyright 2019 © ChemicalBook. All rights reserved